Legend Biotech Corporation
LEGN
$18.55
-$0.55-2.88%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -67.68% | 31.15% | -14.14% | 53.19% | 65.85% |
| Total Depreciation and Amortization | 35.05% | 17.29% | 3.40% | 4.79% | 15.33% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3,935.29% | 27.36% | 496.03% | -45.20% | -103.87% |
| Change in Net Operating Assets | -605.98% | -304.88% | -322.81% | -373.51% | 125.80% |
| Cash from Operations | 30.42% | -7.89% | -92.58% | -10.37% | 63.38% |
| Capital Expenditure | -102.84% | -15.75% | 19.19% | 55.31% | 29.79% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 188.25% | 100.54% | 139.81% | 36.78% | -841.12% |
| Cash from Investing | 183.42% | 95.27% | 137.20% | 38.07% | -1,016.73% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 10.00% | -28.15% | -23.60% | -8.65% | -6.52% |
| Issuance of Common Stock | -65.98% | -63.26% | 10.08% | -98.80% | -98.78% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -105.26% | -99.77% | -2.21% | -99.30% | -99.28% |
| Foreign Exchange rate Adjustments | 390.48% | 288.56% | 1,112.80% | -113.26% | -407.92% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 162.08% | 64.22% | 106.33% | -291.94% | -301.55% |